Table 3.
Effects of ADSCs on peripheral blood.
| Variables | Time | Sham (n = 6) | P value | IRI (n = 6) | P value | ADSCs (n = 6) | P value | |||
|---|---|---|---|---|---|---|---|---|---|---|
| P 1 | P 1 | P 2 | P 1 | P 2 | P 3 | |||||
| White blood cell (×109/L) | Preoperative | 19.13 ± 4.32 | 16.50 ± 3.95 | 17.82 ± 2.10 | ||||||
| 1d | 22.03 ± 3.26 | 0.183 | 33.57 ± 10.14▲▲,∗∗ | 0.000 | 0.006 | 23.70 ± 2.50▲▲,# | 0.000 | 0.654 | 0.016 | |
| 3d | 19.42 ± 3.91 | 0.894 | 27.08 ± 5.93▲,∗∗ | 0.010 | 0.007 | 20.12 ± 2.04# | 0.078 | 0.780 | 0.013 | |
| 7d | 16.28 ± 2.88 | 0.190 | 20.92 ± 3.57∗ | 0.249 | 0.013 | 18.05 ± 1.88 | 0.113 | 0.302 | 0.103 | |
|
| ||||||||||
| Neutrophil (×109/L) | Preoperative | 7.85 ± 0.94 | 7.07 ± 1.20 | 7.10 ± 0.82 | ||||||
| 1d | 14.27 ± 1.96▲▲ | 0.000 | 24.25 ± 3.52▲▲,∗∗ | 0.000 | 0.000 | 18.70 ± 2.10▲▲,∗,## | 0.000 | 0.010 | 0.002 | |
| 3d | 8.53 ± 3.02 | 0.563 | 17.23±3.07∗∗ | 0.316 | 0.000 | 12.22 ± 1.93▲▲,∗,## | 0.000 | 0.033 | 0.006 | |
| 7d | 9.27 ± 1.55 | 0.237 | 9.42 ± 1.21 | 0.115 | 0.830 | 8.58 ± 0.60 | 0.106 | 0.334 | 0.243 | |
|
| ||||||||||
| Lymphocyte (×109/L) | Preoperative | 7.20 ± 2.57 | 7.17 ± 2.12 | 7.65 ± 0.39 | ||||||
| 1d | 11.48 ± 1.96▲ | 0.0140. | 18.75 ± 3.4▲▲,∗∗ | 0.000 | 0.000 | 13.00 ± 0.6▲▲,## | 0.000 | 0.275 | 0.001 | |
| 3d | 10.87 ± 2.95▲ | 032 | 13.65 ± 1.41▲▲,∗ | 0.000 | 0.025 | 9.57 ± 0.80▲▲,## | 0.000 | 0.265 | 0.002 | |
| 7d | 7.17 ± 3.34 | 0.983 | 8.40 ± 1.54 | 0.360 | 0.335 | 8.07 ± 0.53 | 0.242 | 0.478 | 0.791 | |
IRI: ischemia-reperfusion injury; ADSCs: adipose-derived mesenchymal stem cells. ▲P1 < 0.05, preoperative comparison with different time points (▲▲P1 < 0.01); ∗P2 < 0.05, compared to the sham group (∗∗P2 < 0.01); #P3 < 0.05, compared to the IRI group (##P3 < 0.01).